16-3247221-C-T

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBP6

The NM_000243.3(MEFV):​c.1382G>A​(p.Arg461Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000141 in 1,614,126 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R461P) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00068 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000085 ( 0 hom. )

Consequence

MEFV
NM_000243.3 missense

Scores

1
17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:1

Conservation

PhyloP100: -0.108

Publications

5 publications found
Variant links:
Genes affected
MEFV (HGNC:6998): (MEFV innate immunity regulator, pyrin) This gene encodes a protein, also known as pyrin or marenostrin, that is an important modulator of innate immunity. Mutations in this gene are associated with Mediterranean fever, a hereditary periodic fever syndrome. [provided by RefSeq, Jul 2008]
MEFV Gene-Disease associations (from GenCC):
  • familial Mediterranean fever
    Inheritance: AD, AR, SD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Myriad Women’s Health, ClinGen
  • autosomal recessive familial Mediterranean fever
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • familial Mediterranean fever, autosomal dominant
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.007375896).
BP6
Variant 16-3247221-C-T is Benign according to our data. Variant chr16-3247221-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 234362.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000243.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MEFV
NM_000243.3
MANE Select
c.1382G>Ap.Arg461Gln
missense
Exon 5 of 10NP_000234.1
MEFV
NM_001198536.2
c.749G>Ap.Arg250Gln
missense
Exon 4 of 9NP_001185465.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MEFV
ENST00000219596.6
TSL:1 MANE Select
c.1382G>Ap.Arg461Gln
missense
Exon 5 of 10ENSP00000219596.1
MEFV
ENST00000541159.5
TSL:1
c.749G>Ap.Arg250Gln
missense
Exon 4 of 9ENSP00000438711.1
MEFV
ENST00000539145.5
TSL:1
n.*15G>A
non_coding_transcript_exon
Exon 2 of 7ENSP00000444471.1

Frequencies

GnomAD3 genomes
AF:
0.000677
AC:
103
AN:
152152
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00227
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000328
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.000956
GnomAD2 exomes
AF:
0.000219
AC:
55
AN:
251466
AF XY:
0.000199
show subpopulations
Gnomad AFR exome
AF:
0.00283
Gnomad AMR exome
AF:
0.000173
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000264
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000848
AC:
124
AN:
1461856
Hom.:
0
Cov.:
33
AF XY:
0.0000660
AC XY:
48
AN XY:
727224
show subpopulations
African (AFR)
AF:
0.00299
AC:
100
AN:
33478
American (AMR)
AF:
0.000246
AC:
11
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86254
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53398
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.00000809
AC:
9
AN:
1112004
Other (OTH)
AF:
0.0000662
AC:
4
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.458
Heterozygous variant carriers
0
9
17
26
34
43
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000676
AC:
103
AN:
152270
Hom.:
0
Cov.:
31
AF XY:
0.000618
AC XY:
46
AN XY:
74438
show subpopulations
African (AFR)
AF:
0.00226
AC:
94
AN:
41560
American (AMR)
AF:
0.000327
AC:
5
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5176
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68020
Other (OTH)
AF:
0.000946
AC:
2
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
6
12
18
24
30
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000386
Hom.:
0
Bravo
AF:
0.000680
ESP6500AA
AF:
0.00228
AC:
10
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000206
AC:
25

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:3
May 12, 2017
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: The MEFV c.1382G>A (p.Arg461Gln) variant involves the alteration of a non-conserved nucleotide. 4/4 in silico tools predict a benign outcome for this variant (SNPsandGO not captured due to low reliability index). This variant was found in 25/121320 control chromosomes at a frequency of 0.0002061, which does not exceed the estimated maximal expected allele frequency of a pathogenic MEFV variant (0.0216506). In addition, one clinical diagnostic laboratory classified this variant as uncertain significance. The variant of interest has not, to our knowledge, been reported in affected individuals via publications and/or reputable databases/clinical diagnostic laboratories; nor evaluated for functional impact by in vivo/vitro studies. Because of the absence of clinical information and the lack of functional studies, the variant is classified as a variant of uncertain significance (VUS) until additional information becomes available.

Feb 20, 2018
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The R461Q missense substitution in the MEFV gene has also neither been published as a pathogenic variant, nor reported as a benign polymorphism, to our knowledge. R461Q represents a non-conservative amino acid substitution, as a positively-charged Arginine residue is replaced with a neutral, polar Glutamine residue. However, the position in the MEFV protein where this substitution occurs is not highly conserved among species. Therefore, based on the currently available information, it is unclear whether R461Q is a pathogenic variant or a rare benign variant.

Oct 24, 2019
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The MEFV c.1382G>A; p.Arg461Gln variant (rs145637617), to our knowledge, is not reported in the medical literature but is reported in ClinVar (Variation ID: 234362). This variant is found in the general population with an overall allele frequency of 0.028 % (82 / 282,866 alleles) in the Genome Aggregation Database. The arginine at codon 461 is highly conserved, but computational analyses (SIFT, PolyPhen-2) predict that this variant is tolerated. Due to limited information, the clinical significance of the p.Arg461Gln variant is uncertain at this time.

Familial Mediterranean fever Benign:1
Dec 24, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.089
BayesDel_addAF
Benign
-0.54
T
BayesDel_noAF
Benign
-0.56
CADD
Benign
6.9
DANN
Benign
0.84
DEOGEN2
Benign
0.32
T
Eigen
Benign
-0.81
Eigen_PC
Benign
-0.92
FATHMM_MKL
Benign
0.013
N
LIST_S2
Uncertain
0.86
D
M_CAP
Benign
0.018
T
MetaRNN
Benign
0.0074
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.6
L
PhyloP100
-0.11
PrimateAI
Benign
0.23
T
PROVEAN
Benign
-1.2
N
REVEL
Benign
0.082
Sift
Benign
0.37
T
Sift4G
Benign
0.35
T
Polyphen
0.54
P
Vest4
0.12
MVP
0.67
MPC
0.21
ClinPred
0.0034
T
GERP RS
-1.8
Varity_R
0.12
gMVP
0.11
Mutation Taster
=80/20
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs145637617; hg19: chr16-3297221; COSMIC: COSV104376125; API